RLAY
Relay Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.59B
P/E Ratio
—
EPS
$-1.61
Beta
1.58
52W High
$14.64
52W Low
$2.17
50-Day MA
$9.44
200-Day MA
$6.54
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Relay Therapeutics Inc
Relay Therapeutics, Inc. is a clinical-stage precision drug company. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $15.36M |
| Gross Profit (TTM) | $-244.15M |
| EBITDA | $-299.18M |
| Operating Margin | -899.00% |
| Return on Equity | -41.10% |
| Return on Assets | -25.40% |
| Revenue/Share (TTM) | $0.09 |
| Book Value | $3.26 |
| Price-to-Book | 3.95 |
| Price-to-Sales (TTM) | 168.89 |
| EV/Revenue | 111.96 |
| EV/EBITDA | -0.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -23.30% |
| Shares Outstanding | $178.73M |
| Float | $93.67M |
| % Insiders | 1.27% |
| % Institutions | 102.58% |
Analyst Ratings
Consensus ($17.09 target)
2
Strong Buy10
BuyData last updated: 4/9/2026